Vitexin Mitigates <i>Staphylococcus aureus</i>-Induced Mastitis via Regulation of ROS/ER Stress/NF-<i>κ</i>B/MAPK Pathway

Chen, Yu; Yang, Jing; Huang, Zhi; Yin, Baoyi; Umar, Talha; Yang, Cheng; Zhang, Xiangqian; Jing, Hongyuan; Guo, Shuai; Guo, Mengyao; Deng, Ganzhen; Qiu, Changwei

doi:https://doi.org/10.1155/2022/7977433

Oxidative Medicine and Cellular Longevity

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Abbreviations Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Special Issue

Bioactive Compounds of Food: Their Role in the Prevention and Treatment of Diseases 2022

View this Special Issue

Research Article | Open Access

Volume 2022 | Article ID 7977433 | https://doi.org/10.1155/2022/7977433

Vitexin Mitigates Staphylococcus aureus-Induced Mastitis via Regulation of ROS/ER Stress/NF-κB/MAPK Pathway

Yu Chen,¹Jing Yang,¹Zhi Huang,¹Baoyi Yin,¹Talha Umar,¹Cheng Yang,¹Xiangqian Zhang,¹Hongyuan Jing,¹Shuai Guo,¹Mengyao Guo,²Ganzhen Deng,¹and Changwei Qiu¹

Academic Editor: Cassiano Felippe Gonçalves-de-Albuquerque

Received11 Mar 2022

Revised02 Jun 2022

Accepted14 Jun 2022

Published27 Jun 2022

Abstract

Mastitis, caused by a variety of pathogenic microorganisms, seriously threatens the safety and economic benefits of the dairy industry. Vitexin, a flavone glucoside found in many plant species, has been widely reported to have antioxidant, anti-inflammatory, antiviral, anticancer, neuroprotective, and cardioprotective effects. However, few studies have explored the effect of vitexin on mastitis. This study is aimed at exploring whether the antioxidant and anti-inflammatory functions of vitexin can improve Staphylococcus aureus-induced mastitis and its possible molecular mechanism. The expression profiles of S. aureus-infected bovine mammary epithelial cells and gland tissues from the GEO data set (GSE94056 and GSE139612) were analyzed and found that DEGs were mainly involved in immune signaling pathways, apoptosis, and ER stress through GO and KEGG enrichment. Vitexin blocked the production of ROS and increased the activity of antioxidant enzymes (SOD, GSH-PX, and CAT) via activation of PPARγ in vivo and in vitro. In addition, vitexin reduced the production of inflammatory cytokines (TNF-α, IL-1β, and IL-6) and inhibited apoptosis in MAC-T cells and mouse mammary tissues infected with Staphylococcus aureus. Moreover, vitexin decreased the expression of PDI, Ero1-Lα, p-IRE1α, PERK, p-eIF2α, and CHOP protein but increased BiP in both mammary gland cells and tissues challenged by S. aureus. Western blot results also found that the phosphorylation levels of JNK, ERK, p38, and p65 were reduced in vitexin-treated tissues and cells. Vitexin inhibited the production of ROS through promoting PPARγ, increased the activity of antioxidant enzymes, and reduced inflammatory cytokines and apoptosis by alleviating ER stress and inactivation MAPKs and NF-κB signaling pathway. Vitexin maybe have great potential to be a preventive and therapeutic agent for mastitis.

1. Introduction

Staphylococcus aureus (S. aureus) is an important pathogenic microorganism that causes food-borne infections, and it is also the main pathogen that causes mastitis in ruminants [1, 2]. Milk produced by cows suffering from S. aureus mastitis is one of the most important sources of milk contamination, whereas raw milk and dairy products are the natural medium for the growth of S. aureus [3]. S. aureus is a common opportunistic pathogen in the farm environment. Lactating dairy cows are highly susceptible to infection and transmission of S. aureus due to open lactation passages and exposure to contaminants such as milking equipment. The exotoxin produced by S. aureus can easily cause food poisoning [4]. Once exotoxin enters the gut, the T-cell inflammatory cytokine storm is triggered in the host [5, 6]. S. aureus is a common pathogen of dairy cow mastitis, which seriously affects milk production and quality and causes huge economic losses to the dairy industry [7, 8]. The mechanisms by which S. aureus challenge the host immune response are complicated. During the colonization and invasion of S. aureus, white blood cells are recruited to the site of infection, and white blood cells produce a series of reactive substances (including superoxide, hydrogen peroxide, nitric oxide, and hypohalous acid), which can modify and inactivate cells large molecules, even lead to growth defects or death [9]. Oxidative stress caused by S. aureus produces oxidants that react with cell macromolecules [10]. The accumulation of a large number of reactive oxygen species (ROS) attacked oxidized proteins, lipids, and DNA to cause oxidative damage is a characteristic of many inflammatory diseases [11]. ROS causes endoplasmic reticulum (ER) stress, which breaks the ER redox environment and induces protein folding errors [12, 13]. Persistent ER stress can also trigger an inflammatory response through the unfolded protein response (UPR) pathway [14]. ER participates in the modification (including disulfide bonds, aminoglycosylation, and folding) of secreted proteins and transmembrane proteins. Immunoglobulin heavy chain binding protein (BiP) and protein disulfide isomerase (PDI), molecular chaperone proteins in the ER, play an important role in protein folding and oxidation [15]. Protein kinase R- (PKR-) like endoplasmic reticulum kinase (PERK) and inositol-requiring enzyme 1α (IRE1α) serve as a quality controller for protein synthesis in the endoplasmic reticulum [16–18]. Once UPR is activated in the context of ER stress, BiP will separate from PERK and IRE1α and cause their activation, promoting the transcription of ER stress response genes [16, 19]. PERK directly phosphorylates eIF2α after autophosphorylation, thereby reducing protein translation and promoting the production of C/EBP homologous protein (CHOP) [20]. Elevated CHOP plays an important role in apoptosis induced by ER stress [21]. S. aureus also induced a cell-mediated immune response in the mouse mammary gland, which significantly promoted the production of IFN-γ and increased the percentage of CD4⁺ and CD8⁺ T cells [22]. The treatment of dairy cow mastitis usually uses antibiotics including penicillin, sulfonamides, tetracyclines, and glycopeptides [23]. However, the emergence of antibiotic resistance to S. aureus (such as methicillin-resistant S. aureus) complicates the treatment [24, 25]. Natural compounds have a variety of biological activities (anti-inflammatory, antioxidant, anticancer, etc.), which is a huge treasure house for screening potential mastitis treatment drugs.

Vitexin (8-beta-D-glucopyranosyl-apigenin) is an apigenin flavonoid glycoside found in food and medicinal plants, which has a variety of pharmacological effects, including anti-inflammatory, anticancer, antioxidant, analgesic, and neuroprotective effects [26, 27]. Vitexin inhibited the recruitment of neutrophils and also regulated the transcription factors of proinflammatory mediators and reduced the expression of p-p38, p-ERK1/2, and p-JNK in LPS-induced cells [28]. Studies have reported that vitexin repressed the activation of TLR4/NF-κB signaling pathway in colitis liver injury [29]. Many studies have also found that vitexin exerts anti-inflammatory effects on endothelial cell damage [30], acute lung injury [31], allergic asthma [32], and neuroinflammation [33]. Both in vitro and in vivo data show that vitexin can enhance the body’s antioxidant capacity and reduce the occurrence of oxidative stress [34]. Vitexin has been proven to produce a powerful antioxidant defense by acting as an effective oxygen free radical scavenger to increase the activity of antioxidant enzymes and upregulate the protein of antioxidant reactions [35]. Based on the various biological activity properties of vitexin, we hypothesized that vitexin could improve the oxidative stress and inflammation induced by S. aureus.

In this study, to confirm the therapeutic effect of vitexin on mastitis stimulated by S. aureus, we simulated mastitis on cow mammary epithelial cells and mouse mammary glands in vitro and in vivo and explored the possible molecular mechanisms of vitexin exerting antioxidation and anti-inflammation.

2. Materials and Methods

2.1. High Pressure Liquid Chromatography (HPLC)

HPLC was performed to measure vitexin purity. Briefly, vitexin was diluted to 0.5 mg/mL by the solution (). 20 μL vitexin was added to a SinoChrom ODS-BP chromatographic column (, 5 μm). Hereafter, the 0.1% phosphate water/acetonitrile mobile phase was used to elute. The flow rate was 1.0 mL/min, and the detection wavelength was 335 nm.

2.2. Cell Culture and Treatment

The cow mammary epithelial cell line MAC-T was purchased from the American Type Culture Collection (ATCC, USA). The cell culture method was referred to previous studies [36]. Briefly, cells were grown in DMEM/F-12 (1 : 1) medium (Gibco, USA) supplemented with 10% fetal bovine serum (FBS; AUSGENEX, AUS), 5 μg/mL insulin (Biosharp, China), 5 mmol/L L-glutamine (Biosharp, China), 1 μg/mL hydrocortisone (Sigma-Aldrich, USA), and 100 U/mL penicillin and 100 μg/mL streptomycin (Invitrogen, USA) at 37°C incubator with 5% CO₂. S. aureus CVCC3051 strain was available at China Veterinary Culture Collection (CVCC, China), which was cultured with lysogeny broth (LB) and its colony forming unit (CFU) was calculated using the LB plate counting method. S. aureus was inactivated in a water bath at 85°C for 15 min and then diluted it with DMEM/F-12 medium according to CFU. MAC-T cells were seeded into a six-well plate at cells/well. When the degree of cell fusion reached 60%-70%, S. aureus was added to the four wells of the six-well plate at a multiplicity of infection (MOI) of 100. After infected for 6 h, different concentrations of vitexin were added to the four wells, respectively. The six groups are (1) Control, (2) S. aureus, (3) S. aureus+10 μM vitexin, (4) S. aureus+20 μM vitexin, (5) S. aureus+40 μM vitexin, and (6) 40 μM vitexin. After incubating for another 24 h, cell samples were harvested for RNA or protein extraction.

2.3. Cell Counting Kit-8 (CCK-8) Assay

The effect of vitexin on the viability of MAC-T cells was analyzed by CCK-8. Detailed methods referred to previous research [37]. In short, MAC-T cells were planted into 96-well plates at a density of cells/well, and then, the cells were treated with different concentrations of vitexin (0, 10, 20, and 40 μM) for 24 h. 10 μL CCK-8 reagent (Yeasen, Shanghai, China) was added to each well and incubated at 37°C for 4 h. The microplate reader measured the OD value at 450 nm.

2.4. Flow Cytometry Analysis

Apoptosis was examined with Annexin V-FITC/PI Double Stain Apoptosis Detection Kit (BestBio, China). MAC-T cells were treated with S. aureus and/or vitexin, and then, the cells were digested and centrifuged to collect suspended cells. 400 μL 1× Annexin V binding solution was used to resuspend the cells at a concentration of approximately cells/mL. Then, 5 μL Annexin V-FITC solution was added to the cell suspension, mixed gently, and incubated for 15 min at 4°C in the dark. Then, 5 μL PI was added and incubated for 5 min at 4°C in the dark. Finally, the flow cytometer was hired immediately to obtain the results.

2.5. Mouse and Mastitis Animal Models

A total of 60 KM female mice (6-7 weeks old, 32–34 g weight) were gained and fed in Huazhong Agricultural University Laboratory Animal Research Center (Wuhan, China). All mice were allowed to obtain food and water ad libitum in the environment maintained at and 65% humidity. All procedures of this study were carried out in accordance with standards provided by the Ethical Committee on Animal Research at Huazhong Agricultural University.

All mice were randomly divided into 6 groups: control group, S. aureus group, S. aureus + vitexin (15, 30, and 60 mg/kg) groups, and vitexin (60 mg/kg) group. S. aureus was injected into the mammary ducts of mice to produce mastitis in mice according to previous studies [7]. Vitexin was diluted with sterile PBS to 20 mg/mL. After mouse mammary gland infection with S. aureus for 24 h, the control group was intraperitoneally injected with sterile PBS. As the previous study described the dosage of vitexin [38, 39], the S. aureus + vitexin (15, 30, and 60 mg/kg) groups were intraperitoneally injected with vitexin at different doses (15, 30, and 60 mg/kg); the vitexin (60 mg/kg) group was intraperitoneally injected with vitexin at 60 mg/kg. All groups were injected three times with an interval of 8 h. Then, the mice were euthanized at 8 h after the last drug treatment, and breast tissues were harvested and stored at −80°C refrigerator.

2.6. Hematoxylin and Eosin (H&E) Staining

H&E staining was used to evaluate the histopathology of S. aureus infection in mouse breast tissue. The experimental method was in accordance with the previous research [40]. In short, the collected fresh mouse breast tissue was immediately fixed in 4% paraformaldehyde solution, paraffin embedded, sectioned, transparent, dehydrated, and H&E stained. Finally, the histopathological changes were checked by an optical microscope.

2.7. Myeloperoxidase (MPO) Activity

MPO Assay Kit (Nanjing Jiancheng Bioengineering Institute, China) was bought to detect MPO activity. The mouse mammary gland tissue was accurately weighed, and the homogenization medium () was added to prepare a 5% tissue homogenate.

2.8. Enzyme-Linked Immunosorbent Assay (ELISA)

The effect of vitexin on proinflammatory cytokine production was examined in S. aureus challenge-MAC-T cells and mouse breast tissues. The concentration of TNF-α, IL-1β, and IL-6 was detected by ELISA kits (BioLegend, San Diego, CA, USA) following the manufacturer’s instructions.

2.9. ROS Detection

Intracellular ROS level was measured with DHE-ROS Detection Kit (BestBio, Shanghai, China) according to the manufacturer’s manual. Briefly, MAC-T cells were pretreated for 30 min with GW9662 (10 μM) or GW1929 (10 μM) to downregulate or upregulate the expression of PPARγ, respectively. Cells were stimulated with S. aureus to mimic inflammatory stimulation and then treated with vitexin (40 μM) for 24 h. The DHE probe was diluted 1000 times with DMEM/F-12 medium and then added to the cells to continue to incubate in the dark for 30 min at 37°C. The cells were washed with PBS to remove the DHE probe and finally observed with a fluorescence microscope at the excitation wavelength (Ex) of 535 nm and the emission wavelength (Em) of 610 nm.

Tissue ROS Detection Kit (BBoxiProbe O13®) was obtained from BestBio (Shanghai, China). The harvested fresh mouse mammary gland tissue was accurately weighed and then prepared into a homogenizer with a glass homogenizer. The homogenate supernatant was collected by centrifugation and added into 96-well plate with 2 μL probe O13. After incubating for 30 min at 37°C in the dark, the fluorescence intensity was detected with a fluorescence microplate reader at nm.

2.10. Antioxidant Biochemical Indicators

Total antioxidant capacity (T-AOC), superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), catalase (CAT), and malondialdehyde (MDA) were determined to assess antioxidant capacity. T-AOC assay kit, SOD assay kit (WST-1 method), GSH-PX assay kit, CAT assay kit (visible light), and MDA assay kit (TBA method) were bought from Nanjing Jiancheng Bioengineering Institute (Nanjing, China), and the inspection process was carried out in accordance with the instructions.

2.11. Real Time-Quantitative Polymerase Chain Reaction (RT-qPCR)

The total RNA of mouse mammary gland tissue and MAC-T cells was extracted with TRIzol reagent (Solarbio, Beijing). Q5000 ultramicro spectrophotometer (Quawell, USA) was used to evaluate RNA purity and measure RNA concentration. Hifair® III 1st Strand cDNA Synthesis SuperMix for qPCR (gDNA digester plus) and Hieff® qPCR SYBR® Green Master Mix were acquired from Yeasen (Shanghai, China) and used to examine target gene expression by qPCR with 2^−ΔΔCq method. The primers used in this study are shown in Table 1.

2.12. Western Blot

The total protein of mouse breast tissues and MAC-T cells was separated by RIPA reagent (Biosharp, China). The BCA Protein Assay Kit (Thermo Scientific, MA, USA) was performed to detect protein concentration. The protein was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE); then, polyvinylidene difluoride (PVDF) membranes were used to receive the transferred protein from the gel. The membranes were blocked with 5% skimmed milk for 2 h; then, the primary antibodies (BiP, Ero1-Lα, PDI, IRE1α, PERK, CHOP, JNK, ERK, p38, p65, and β-actin from Cell Signaling Technology, USA; PPARγ from Abcam, UK) were incubated at 4°C overnight, and then, the secondary antibody (anti-rabbit IgG and HRP-linked antibody from Cell Signaling Technology, USA) was incubated at 37°C for 1 h. Finally, the immunoblot signal was displayed with ECL ultrasensitive chemiluminescent solution with chemiluminescence imaging system.

2.13. Bioinformatics Analysis

Expression profiles of S. aureus-infected bovine mammary epithelial cells and glandular cistern (GSE94056 and GSE139612) were downloaded from the GEO dataset (https://www.ncbi.nlm.nih.gov/gds/?term=). Differentially expressed genes (DEGs) were screened from these two datasets, and common DEGs were further analyzed by the online tool Draw Venn Diagrams (http://bioinformatics.psb.ugent.be/webtools/Venn/). Gene Ontology Resource (GO, http://geneontology.org/) and Kyoto Encyclopedia of Genes and Genomes (KEGG, https://www.kegg.jp/) were used to analyze GO and KEGG enrichment of common DEGs. In addition, protein-protein interaction (PPI) network was built by STRING database (https://string-db.org/).

The druggability of vitexin was assessed by the Traditional Chinese Medicine System Pharmacology Database (TCMSP, https://tcmspw.com/), and the potential targets of vitexin were identified using SwissTarget Prediction (http://www.swisstargetprediction.ch/).

2.14. Statistical Analysis

Statistical analysis was processed with the GraphPad Prism 9.00 software. Statistical data were expressed as of three individual experiments. After the normality test, differences between groups were analyzed by one-way ANOVA or Student’s -tests. # vs. the control group, vs. the S. aureus group, and vs. the S. aureus group.

3. Results

3.1. DEG Analysis of S. aureus-Induced Mastitis from GEO Database

Given that the host infection event usually undergoes a large number of complex gene expression changes, we analyzed the expression profiles of bovine mammary epithelial cell and gland cistern infected with S. aureus from the GEO dataset (GSE94056 and GSE139612) [41, 42]. In these two GEO datasets, GEO2R was used to analyze the DEGs [43, 44]. Furthermore, the intersection of these DEGs was calculated through drawing Venn diagrams. The DEGs of two GEO datasets contained 283 identical DEGs (Figure 1(a)). These 283 DEGs were further analyzed by KEGG and GO enrichment. We found that these DEGs mainly involve innate immunity and apoptosis signaling pathways (MAPK signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, etc.) (Figure 1(b)). The biological process that DEGs participated in included extracellular structure organization, extracellular matrix organization, small GTPase-mediated signal transduction, muscle cell differentiation, positive regulation of cell adhesion, regulation of small GTPase-mediated signal transduction, positive regulation of GTPase activity, regulation of muscle cell differentiation, platelet degranulation, and adherens junction organization (Figure 1(c)). These DEGs were involved in the extracellular matrix, collagen-containing extracellular matrix and glutamatergic synapses in cellular components term (Figure 1(d)). The molecular functions of these DEGs were enzyme activator activity, GTPase regulator activity, nucleoside-triphosphatase regulator activity, GTPase activator activity, extracellular matrix structural constituent, integrin binding, extracellular matrix structural constituent, conferring compression resistance, and MAP kinase activity (Figure 1(e)). To further explore the interaction between these DEGs, we used the STRING database to build an interaction network diagram (Figure 1(f)) and built an interaction network diagram for the extremely significant DEGs separately (Figure 1(g)).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

3.2. Network Pharmacology Analysis of Vitexin

As displayed in Figure 2, our results showed that vitexin has good druggability with 79 potential target genes. There were three target genes (PPARγ, MMP2, and GCGR) that intersect with common DEGs, among which PPARγ was involved in oxidative stress.

(a)

(b)

(c)

(d)

3.3. The Purified Substance Vitexin Had No Effect on the Viability of MAC-T Cells

Vitexin is the natural 8-C glucoside of the flavone apigenin (mung bean [45], chia leaf [46], Prosopis cineraria leaves [47], etc.), which is very likely to become a natural antioxidant. As illustrated in Figure 3(a), vitexin is a flavone glucoside, also known as apigenin-8-C-β-D-glucopyranoside. The purity of the extracted vitexin was detected by HPLC, and the extract was found to be a high-purity vitexin (Figure 3(b)). For the follow-up in vivo and in vitro experiments of vitexin, we tested and analyzed the effect of vitexin on cytotoxicity through CCK-8. CCK-8 results showed that vitexin was not toxic to MAC-T cells at least in the concentration range below 40 μM (Figure 3(c)).

(a)

(b)

(c)

3.4. Vitexin Ameliorated Cell Damage on S. aureus Challenged-MAC-T Cells

MAC-T cells infected with S. aureus experienced significant apoptosis (Figure 4(a)). But vitexin reduced the apoptosis rate of S. aureus-infected MAC-T cells in a dose-dependent manner (Figure 4(b)). In addition, the level of proinflammatory cytokine production was evaluated in S. aureus-induced MAC-T cells by qPCR and ELISA. The mRNA level of proinflammatory cytokines was greatly increased under the stimulation of S. aureus. On the other hand, vitexin inhibited the production of inflammatory factors in a dose-dependent manner (Figures 4(c)–4(e)). The released TNF-α, IL-1β, and IL-6 concentrations in the cell supernatant were evaluated by ELISA, whose results were consistent with the trend of qPCR (Figures 4(f)–4(h)).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Figure 4

Vitexin ameliorated cell damage on S. aureus challenged-MAC-T cells. (a) MAC-T cells were stimulated with S. aureus at MOI of 100 for 6 h. And then, different concentrations of vitexin (10, 20, and 40 μM) were added to coincubate for 24 h. Flow cytometry was used to evaluate the effect of vitexin on the apoptosis of MAC-T cells stimulated by S. aureus. The horizontal axis represented Annexin V-FITC, and the vertical axis expressed PI. (b) Flow cytometry results were statistically analyzed for apoptosis rate by the GraphPad Prism 9.00 software. (c–e) The cells were dealt with S. aureus and/or vitexin; the relative expression of TNF-α, IL-1β, and IL-6 mRNA was examined by RT-qPCR. GAPDH served as an internal reference gene. (f–h) The proinflammatory factors produced were tested by ELISA. Data were presented as of three independent experiments. # vs. the control group. vs. the S. aureus group; vs. the S. aureus group.

3.5. Vitexin Inhibited ROS Production on S. aureus Stimulated-MAC-T Cells

The level of intracellular ROS was evaluated by DHE probe, and the results revealed that S. aureus infection of MAC-T cells rapidly promoted the production of intracellular ROS. However, vitexin could effectively suppress the MAC-T cells stimulated by S. aureus to produce a large amount of ROS (Figures 5(a) and 5(b)). The body’s antioxidant capacity is closely related to enzymes such as SOD, GSH-PX, and CAT, which eliminate free radicals and ROS so as not to trigger lipid peroxidation. We tested the T-AOC and the abovementioned enzyme activity. The T-AOC and enzyme activities of SOD, GSH-PX, and CAT in MAC-T cells stimulated by S. aureus were much lower than control, but vitexin obviously increased the T-AOC, SOD, GSH-PX, and CAT activities on S. aureus challenged-MAC-T cells (Figures 5(c)–5(f)). Conversely, vitexin prevented the production of MDA in a dose-dependent manner on MAC-T cells stimulated by S. aureus (Figure 5(g)). To further explore the mechanism of the antioxidant effect of vitexin, PPARγ was predicted as an interacting protein by investigating the possible target genes of vitexin. Western blot results revealed that PPARγ was inhibited after S. aureus infection, whereas vitexin greatly promoted PPARγ expression (Figures 5(h) and 5(i)). Agonists (GW1929) and antagonists (GW9662) of PPARγ were hired to further study the effect of vitexin on PPARγ. As shown in Figure 5(j), vitexin, like PPARγ antagonists, reduced ROS levels in uninfected cells. ROS levels increased sharply under S. aureus stimulation, whereas agonists significantly reduced ROS levels in S. aureus-stimulated cells and were less effective than vitexin and agonist combination treatment. Meanwhile, PPARγ antagonists accelerated the increase of ROS in S. aureus-infected cells, but when antagonists were used in combination with vitexin, GW9662 prevented the ROS inhibitory effect of vitexin under S. aureus challenge.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

Figure 5

Vitexin inhibited ROS production on S. aureus stimulated-MAC-T cells. (a) The cells were stimulated with S. aureus for 6 h and then treated with different concentrations of vitexin (10, 20, and 40 μM) for 24 h. ROS red fluorescence was displayed with DHE probe. (b) ROS levels were quantified by the ImageJ software. Relative ROS levels were expressed as red fluorescence intensity/cell number. (c) The level of T-AOC. (d) The activity of SOD. (e) The activity of GSH-PX. (f) The activity of CAT. (g) The concentration of MDA. (h) Western blot detection of the expression level of PPARγ. (i) PPARγ gray values were measured by the ImageJ software. (j) MAC-T cells were pretreated with GW9662 (10 μM) or GW1929 (10 μM) for 30 min to downregulate or upregulate the expression of PPARγ, respectively, then stimulated with S. aureus to mimic inflammatory stimulation, and finally treated with vitexin. ROS was detected with DHE probe. Data was expressed as of three independent experiments. # vs. the control group. vs. the S. aureus group; vs. the S. aureus group.

3.6. Vitexin Suppressed the Activation of MAPK and NF-κB Signaling Pathways by Blocking the ER Stress Caused by S. aureus on MAC-T Cells

To investigate the effect of vitexin on ER stress, ER stress-related proteins were examined by Western blot. The levels of BiP in S. aureus-infected cells were lower than normal cells, but vitexin greatly promoted their expression levels under the stimulation of S. aureus. Meanwhile, S. aureus infection drastically increased the expression of PDI, Ero1-Lα, p-IRE1α, PERK, p-eIF2α, and CHOP, while vitexin repressed their expression (Figures 6(a) and 6(b)). In addition, Western blot was also hired to evaluate MAPK and NF-κB signaling pathways. The phosphorylation levels of JNK, ERK, p38, and p65 in S. aureus-induced MAC-T cells dramatically increased compared to the control. Reversely, vitexin significantly restricted the expression of p-JNK, p-ERK, p-p38, and p-p65 (Figures 6(c) and 6(d)).

(a)

(b)

(c)

(d)

Figure 6

Vitexin suppressed the activation of MAPK and NF-κB signaling pathways by blocking the ER stress caused by S. aureus on MAC-T cells. (a) The protein levels of PDI, BiP, Ero1-Lα, p-IRE1α, PERK, p-eIF2α, and CHOP were detected by Western blot on MAC-T cells. (c) The expression levels of JNK, ERK, p38, and p65 proteins in MAC-T cells were determined by Western blot. (b, d) Protein gray values were measured by the ImageJ software. Data was expressed as of three independent experiments. # vs. the control group. vs. the S. aureus group; vs. the S. aureus group.

3.7. Vitexin Improved S. aureus-Induced Mastitis in Mice

A mouse model of mastitis was established to assess the protective effect of vitexin. H&E staining was performed to evaluate the degree of damage to the mammary gland tissue of mice infected with S. aureus. As illustrated in Figure 7(a), the acinar cavity epithelial cells of mice mammary glands were attacked by S. aureus causing degeneration, necrosis, and even shedding to the acinar cavity. At the same time, the acinar cavity was also filled with serum and a large number of neutrophils and macrophages. Vitexin maintained the integrity of the acinar cavity epithelial cells and relieved the infiltration of inflammatory cells. Moreover, MPO was checked to evaluate the degree of inflammation in the mammary gland tissues, and the result indicated that vitexin remarkably suppressed MPO vitality in a dose-dependent manner (Figure 7(b)). In addition, qPCR and ELISA were employed to examine proinflammatory cytokines (TNF-α, IL-1β, and IL-6) which were depressed by vitexin both in mRNA and protein levels (Figures 7(c) and 7(d)).

(a)

(b)

(c)

(d)

Figure 7

Vitexin improved S. aureus-induced mastitis in mice. All mouse mammary gland tissues were stimulated with S. aureus for 24 h, then intraperitoneally injected with different concentrations of vitexin (15, 30, and 60 mg/kg) three times. (a) Histopathological analysis of mammary gland tissues with H&E staining. Left images scale μm, right large images scale μm. (b) The activity of MPO. (c) The expression of TNF-α, IL-1β, and IL-6 mRNA in vivo was measured by RT-qPCR. GAPDH was used as an endogenous control. (d) The proinflammation cytokines TNF-α, IL-1β, and IL-6 in mammary gland tissues were detected by ELISA. Data was expressed as of three independent experiments. # vs. the control group. vs. the S. aureus group; vs. the S. aureus group.

3.8. Vitexin Reduced ROS Production in Mammary Tissues of Mice Infected with S. aureus

The tissue ROS and antioxidant capacity of mice with mastitis were determined. We found that S. aureus infected mouse mammary tissue strikingly increased the level of tissue ROS, whereas vitexin hindered the rise of ROS (Figure 8(a)). Furthermore, vitexin reversed S. aureus induced the fall of T-AOC (Figure 8(b)), SOD (Figure 8(c)), GSH-PX (Figure 8(d)), and CAT (Figure 8(e)). In contrast, MDA level was impeded by vitexin, compared with the S. aureus group (Figure 8(f)). PPARγ protein levels were downregulated in S. aureus-infected cells, and vitexin reversed this decline (Figures 8(g) and 8(h)).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Figure 8

Vitexin reduced ROS production in mammary tissues of mice infected with S. aureus. (a) The level of tissue ROS. (b) The level of T-AOC. (c) The activity of SOD. (d) The activity of GSH-PX. (e) The activity of CAT. (f) The concentration of MDA. (g) PPARγ protein was examined with Western blot. (h) PPARγ gray values were calculated by the ImageJ software. Data was expressed as of three independent experiments. # vs. the control group. vs. the S. aureus group; vs. the S. aureus group.

3.9. Vitexin Relieved ER Stress to Inactivate MAPK and NF-κB Signaling Pathways in S. aureus-Induced Mastitis in Mice

To explore the molecular mechanism of vitexin’s antioxidant and anti-inflammatory effects, Western blot was used to study the protein expression of ER stress and MAPK/NF-κB pathway. As displayed in Figures 9(a) and 9(b), the expression of BiP in the mouse breast tissue stimulated by S. aureus was significantly reduced compared to the control group, while PDI, Ero1-Lα, p-IRE1α, PERK, and CHOP protein levels were restrained in the vitexin-treated mice with mastitis. Besides, p-JNK, p-ERK, p-p38, and p-p65 proteins were decreased in the S. aureus + vitexin group compared with the S. aureus group (Figures 9(c) and 9(d)).

(a)

(b)

(c)

(d)

Figure 9

Vitexin relieved ER stress to inactivate MAPK and NF-κB signaling pathways in S. aureus-induced mastitis on mice. (a) The protein levels of PDI, BiP, Ero1-Lα, p-IRE1α, PERK, p-eIF2α, and CHOP in mammary gland tissues. (c) The expression levels of JNK, ERK, p38, and p65 proteins in mammary gland tissues. (b, d) Protein gray values were measured by the ImageJ software. Data was expressed as of three independent experiments. # vs. the control group. vs. the S. aureus group; vs. the S. aureus group.

4. Discussion

Dairy cow mastitis drastically reduces milk production and milk quality, posing a serious threat to the economic benefits of the dairy industry [25, 48]. The decrease in milk production during mastitis in dairy cows is due to pathogens (such as S. aureus and Escherichia coli) that induce hypoxia, oxidative stress, and apoptosis, while suppressing the expression of milk genes (Csn2, Lalba, and Csn1s1) in the mammary gland [49, 50]. Through the analysis of the GEO dataset (GSE94056 and GSE139612), we also found that S. aureus infection caused a large number of DEGs in the bovine mammary gland tissues and cells, which are inseparable from the activation of oxidative stress induced-ER stress and inflammation-related signaling pathways. Therefore, looking for Chinese herbal medicines that have both antioxidant and anti-inflammatory properties is very likely to become drugs for the treatment of mastitis.

Vitexin, a natural flavonoid compound found in many plant species [35], has been widely reported to have antioxidant, anti-inflammatory, antiviral, neuroprotective, and cardioprotective effects [27, 34]. However, few studies have explored the effect of vitexin on mastitis. In this study, in vivo and in vitro models of mastitis were successfully established. We found that vitexin reduced the production of ROS, protected the activity of antioxidant enzymes, and inhibited cell apoptosis and the production of proinflammatory cytokines in both MAC-T cell and mouse breast tissues. Previous studies have also confirmed that vitexin enhanced cell viability and/or decreased tissue damage by upregulating cell resistance to oxidative stress inducers [30, 31, 51]. Meanwhile, the anti-inflammatory activity of vitexin has attracted more and more attention, and there has been a lot of research involved. Vitexin downregulated the release of inflammatory cytokines (TNF-α, IL-1β, and IL-6) and enzymes (iNOS) by regulating transcription factors and kinases (Nrf-2, NF-κB, and MAPKs) [52, 53]. To explore the molecular mechanism of vitexin’s antioxidation and anti-inflammation, we focused on the connection between ER stress and inflammation.

As a nuclear receptor transcription factor, PPARγ is involved in the regulation of ROS by regulating redox and biosynthetic processes in mitochondria [54, 55]. Activation of PPARγ inhibited oxidative stress and also negatively regulated the expression of AP-1, NF-κB, and other inflammatory response genes [56]. In the present study, PPARγ was found through the intersection of prediction target genes of vitexin and inflammatory disease-related genes. The expression level of PPARγ was suppressed during S. aureus infection, while vitexin treatment enhanced its protein expression. Moreover, GW1929 significantly hindered the increase of ROS in S. aureus-infected cells. GW9662 reversed vitexin-induced ROS inhibition under S. aureus-stimulated conditions. From these results, we speculated that vitexin might alleviate oxidative stress by regulating PPARγ. Oxidative stress is caused by the excessive production of ROS, which interferes with the ER protein folding mechanism to result in the accumulation of abnormal proteins in the ER, thereby causing ER stress [16, 52]. Our study found that vitexin significantly inhibited PDI, Ero1-Lα, p-IRE1α, PERK, and CHOP protein and promoted the expression of BiP in S. aureus-induced mastitis, suggesting that vitexin effectively prevented the production of ROS amplified by ER and programmed cell death triggered by CHOP.

ER stress is also involved in the regulation of immune signal pathways, such as MAPK and NF-κB signaling pathways [57]. IRE1α can stimulate the activation of apoptosis signal kinase-1 (ASK1) and then activate downstream kinases Jun-N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) [21, 58]. In this study, p-JNK, p-ERK, and p-p38 were significantly increased under S. aureus challenge. Vitexin treatment downregulated MAPK signaling proteins in the infected group compared with the untreated group. Therefore, we conjectured that vitexin might reduce the production of inflammatory factors by inhibiting the activation of MAPKs. PERK can also indirectly induce NF-κB through eIF2α [59]. Vitexin inhibited p-p65 protein expression when S. aureus activated p65, indicating that vitexin alleviated inflammation and apoptosis partly by regulating the NF-κB signaling pathway.

5. Conclusion

In summary, S. aureus-induced mastitis produced a large number of DEGs, which were mainly involved in immune signaling pathways, apoptosis, and ER stress. Vitexin could inhibit the production of ROS by promoting PPARγ activity, increased the activity of antioxidant enzymes, and reduced inflammatory cytokines and apoptosis, possibly by alleviating ER stress and inactivation MAPKs and NF-κB signaling pathway (Figure 10). Vitexin may become a potential drug for the treatment of mastitis in dairy cows.

Abbreviations

BiP:	Immunoglobulin heavy chain binding protein
CHOP:	C/EBP-homologous protein
DEGs:	Differentially expressed genes
ER:	Endoplasmic reticulum
Ero1-Lα:	ER-residing protein endoplasmic oxidoreductin-1 like Lα
GO:	Gene ontology
HPLC:	High pressure liquid chromatography
IRE1α:	Inositol-requiring enzyme 1α
JNK:	Jun N-terminal kinase
KEGG:	Kyoto Encyclopedia of Genes and Genomes
MAPK:	Mitogen-activated protein kinase
MPO:	Myeloperoxidase
NF-κB:	Nuclear factor-kappa B
PPI:	Protein-protein interaction network
PPARγ:	Peroxisome proliferator-activated receptor
PDI:	Protein disulfide isomerase
PERK:	Protein kinase R- (PKR-) like endoplasmic reticulum kinase
ROS:	Reactive oxygen species
S. aureus:	Staphylococcus aureus
UPR:	Unfolded protein response.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare no conflict of interests.

Authors’ Contributions

Y. C., G. D., and C. Q. conceived and designed the experiments. Y. C., J. Y., Z. H., B. Y., C. Y., and H. J. carried out the experiments. Y. C., J. Y., T. U., and S. G. processed the data. Y. C. wrote the paper. Y. C., T. U., X. Z., and M. G. revised the manuscript. The final manuscript was read and approved by all authors.

Acknowledgments

This work was funded by the National Natural Science Foundation of China (No. 32172925).

References

J. Kadariya, T. C. Smith, and D. Thapaliya, “Staphylococcus aureus and staphylococcal food-borne disease: an ongoing challenge in public health,” BioMed Research International, vol. 2014, Article ID 827965, 9 pages, 2014.
View at: Google Scholar
G. Abril, T. G. Villa, J. Barros-Velázquez et al., “Staphylococcus aureus exotoxins and their detection in the dairy industry and mastitis,” Toxins, vol. 12, no. 9, p. 537, 2020.
View at: Publisher Site | Google Scholar
K. Artursson, R. Söderlund, L. Liu, S. Monecke, and J. Schelin, “Genotyping of Staphylococcus aureus in bovine mastitis and correlation to phenotypic characteristics,” Veterinary Microbiology, vol. 193, pp. 156–161, 2016.
View at: Publisher Site | Google Scholar
K. Tam and V. J. Torres, “Staphylococcus aureus secreted toxins and extracellular enzymes,” Microbiology spectrum, vol. 7, no. 2, p. 10, 2019.
View at: Publisher Site | Google Scholar
S. Denayer, L. Delbrassinne, Y. Nia, and N. Botteldoorn, “Food-borne outbreak investigation and molecular typing: high diversity of Staphylococcus aureus strains and importance of toxin detection,” Toxins, vol. 9, no. 12, p. 407, 2017.
View at: Publisher Site | Google Scholar
W. R. Schwan, “Staphylococcus aureus toxins: armaments for a significant pathogen,” Toxins, vol. 11, no. 8, p. 457, 2019.
View at: Publisher Site | Google Scholar
Y. Chen, Y. Wang, M. Yang, and M. Y. Guo, “Allicin inhibited Staphylococcus aureus-induced mastitis by reducing lipid raft stability via LxRα in mice,” Journal of Agricultural and Food Chemistry, vol. 67, no. 39, pp. 10863–10870, 2019.
View at: Publisher Site | Google Scholar
Z. B. Zhang, Y. F. Guo, C. Y. Li, C. W. Qiu, and M. Y. Guo, “Selenium influences mmu-miR-155 to inhibit inflammation in Staphylococcus aureus-induced mastitis in mice,” Food & Function, vol. 10, no. 10, pp. 6543–6555, 2019.
View at: Publisher Site | Google Scholar
W. N. Beavers and E. P. Skaar, “Neutrophil-generated oxidative stress and protein damage in Staphylococcus aureus,” Pathogens and disease, vol. 74, no. 6, p. ftw060, 2016.
View at: Publisher Site | Google Scholar
I. Sadowska-Bartosz, S. Galiniak, G. Bartosz, and M. Rachel, “Oxidative modification of proteins in pediatric cystic fibrosis with bacterial infections,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 389629, 10 pages, 2014.
View at: Google Scholar
M. Muzila, K. Rumpunen, H. Wright et al., “Alteration of neutrophil reactive oxygen species production by extracts of devil’s claw (Harpagophytum),” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 3841803, 9 pages, 2016.
View at: Google Scholar
H. M. Zeeshan, G. H. Lee, H. R. Kim, and H. J. Chae, “Endoplasmic reticulum stress and associated ROS,” International Journal of Molecular Sciences, vol. 17, no. 3, p. 327, 2016.
View at: Publisher Site | Google Scholar
C. D. Ochoa, R. F. Wu, and L. S. Terada, “ROS signaling and ER stress in cardiovascular disease,” Molecular Aspects of Medicine, vol. 63, pp. 18–29, 2018.
View at: Publisher Site | Google Scholar
Y. Lin, M. Jiang, W. Chen, T. Zhao, and Y. Wei, “Cancer and ER stress: mutual crosstalk between autophagy, oxidative stress and inflammatory response,” Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, vol. 118, article 109249, 2019.
View at: Publisher Site | Google Scholar
M. Mayer, U. Kies, R. Kammermeier, and J. Buchner, “BiP and PDI cooperate in the oxidative folding of antibodies in vitro,” The Journal of Biological Chemistry, vol. 275, no. 38, pp. 29421–29425, 2000.
View at: Publisher Site | Google Scholar
G. Di Conza and P. C. Ho, “ER stress responses: an emerging modulator for innate immunity,” Cell, vol. 9, no. 3, p. 695, 2020.
View at: Publisher Site | Google Scholar
J. A. Choi and C. H. Song, “Insights into the role of endoplasmic reticulum stress in infectious diseases,” Frontiers in Immunology, vol. 10, p. 3147, 2019.
View at: Google Scholar
J. S. So, “Roles of endoplasmic reticulum stress in immune responses,” Molecules and Cells, vol. 41, no. 8, pp. 705–716, 2018.
View at: Publisher Site | Google Scholar
A. S. Martins, I. Alves, L. Helguero, M. R. Domingues, and B. M. Neves, “The unfolded protein response in homeostasis and modulation of mammalian immune cells,” International Reviews of Immunology, vol. 35, no. 6, pp. 457–476, 2016.
View at: Publisher Site | Google Scholar
S. E. Bettigole and L. H. Glimcher, “Endoplasmic reticulum stress in immunity,” Annual Review of Immunology, vol. 33, no. 1, pp. 107–138, 2015.
View at: Publisher Site | Google Scholar
H. Hu, M. Tian, C. Ding, and S. Yu, “The C/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection,” Frontiers in Immunology, vol. 9, p. 3083, 2018.
View at: Google Scholar
M. I. Gómez, D. O. Sordelli, F. R. Buzzola, and V. E. García, “Induction of cell-mediated immunity to Staphylococcus aureus in the mouse mammary gland by local immunization with a live attenuated mutant,” Infection and Immunity, vol. 70, no. 8, pp. 4254–4260, 2002.
View at: Publisher Site | Google Scholar
M. Z. David and R. S. Daum, “Treatment of Staphylococcus aureus infections,” Current Topics in Microbiology and Immunology, vol. 409, pp. 325–383, 2017.
View at: Publisher Site | Google Scholar
A. M. Algammal, H. F. Hetta, A. Elkelish et al., “Methicillin-resistant Staphylococcus aureus (MRSA): one health perspective approach to the bacterium epidemiology,” Virulence Factors, Antibiotic-Resistance, and Zoonotic Impact, Infection and drug resistance, vol. 13, pp. 3255–3265, 2020.
View at: Publisher Site | Google Scholar
V. Krömker and S. Leimbach, “Mastitis treatment—reduction in antibiotic usage in dairy cows,” Zuchthygiene, vol. 52, Suppl 3, pp. 21–29, 2017.
View at: Publisher Site | Google Scholar
F. Babaei, A. Moafizad, Z. Darvishvand, M. Mirzababaei, H. Hosseinzadeh, and M. Nassiri-Asl, “Review of the effects of vitexin in oxidative stress-related diseases,” Food Science & Nutrition, vol. 8, no. 6, pp. 2569–2580, 2020.
View at: Publisher Site | Google Scholar
M. He, J. W. Min, W. L. Kong, X. H. He, J. X. Li, and B. W. Peng, “A review on the pharmacological effects of vitexin and isovitexin,” Fitoterapia, vol. 115, pp. 74–85, 2016.
View at: Publisher Site | Google Scholar
S. I. Rosa, F. Rios-Santos, S. O. Balogun, and D. T. Martins, “Vitexin reduces neutrophil migration to inflammatory focus by down-regulating pro-inflammatory mediators via inhibition of p38, ERK1/2 and JNK pathway,” Phytomedicine: international journal of phytotherapy and phytopharmacology, vol. 23, no. 1, pp. 9–17, 2016.
View at: Publisher Site | Google Scholar
S. Duan, X. Du, S. Chen et al., “Effect of vitexin on alleviating liver inflammation in a dextran sulfate sodium (DSS)-induced colitis model,” Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, vol. 121, article 109683, 2020.
View at: Publisher Site | Google Scholar
S. Zhang, C. Guo, Z. Chen, P. Zhang, J. Li, and Y. Li, “Retracted: vitexin alleviates ox-LDL-mediated endothelial injury by inducing autophagy via AMPK signaling activation,” Molecular Immunology, vol. 85, pp. 214–221, 2017.
View at: Publisher Site | Google Scholar
Y. Lu, T. Yu, J. Liu, and L. Gu, “Vitexin attenuates lipopolysaccharide-induced acute lung injury by controlling the Nrf2 pathway,” PLoS One, vol. 13, no. 4, article e0196405, 2018.
View at: Publisher Site | Google Scholar
C. L. Venturini, A. Macho, K. Arunachalam et al., “Vitexin inhibits inflammation in murine ovalbumin-induced allergic asthma,” Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, vol. 97, pp. 143–151, 2018.
View at: Publisher Site | Google Scholar
M. Krishnan and S. C. Kang, “Vitexin inhibits acrylamide-induced neuroinflammation and improves behavioral changes in zebrafish larvae,” Neurotoxicology and Teratology, vol. 74, article 106811, 2019.
View at: Publisher Site | Google Scholar
S. Li, T. Liang, Y. Zhang et al., “Vitexin alleviates high-fat diet induced brain oxidative stress and inflammation via anti-oxidant, anti-inflammatory and gut microbiota modulating properties,” Free Radical Biology & Medicine, vol. 171, pp. 332–344, 2021.
View at: Publisher Site | Google Scholar
Y. Peng, R. Gan, H. Li et al., “Absorption, metabolism, and bioactivity of vitexin: recent advances in understanding the efficacy of an important nutraceutical,” Critical Reviews in Food Science and Nutrition, vol. 61, no. 6, pp. 1049–1064, 2021.
View at: Publisher Site | Google Scholar
Y. Chen, H. Jing, M. Chen et al., “Transcriptional profiling of exosomes derived from Staphylococcus aureus-infected bovine mammary epithelial cell line MAC-T by RNA-Seq analysis,” Oxidative Medicine and Cellular Longevity, vol. 2021, Article ID 8460355, 18 pages, 2021.
View at: Google Scholar
Y. Chen, S. Guo, K. Jiang, Y. Wang, M. Yang, and M. Guo, “Glycitin alleviates lipopolysaccharide-induced acute lung injury via inhibiting NF-κB and MAPKs pathway activation in mice,” International Immunopharmacology, vol. 75, article 105749, 2019.
View at: Publisher Site | Google Scholar
J. W. Min, J. J. Hu, M. He et al., “Vitexin reduces hypoxia-ischemia neonatal brain injury by the inhibition of HIF-1alpha in a rat pup model,” Neuropharmacology, vol. 99, pp. 38–50, 2015.
View at: Publisher Site | Google Scholar
J. Jiang, Y. Jia, X. Lu et al., “Vitexin suppresses RANKL-induced osteoclastogenesis and prevents lipopolysaccharide (LPS)-induced osteolysis,” Journal of Cellular Physiology, vol. 234, no. 10, pp. 17549–17560, 2019.
View at: Publisher Site | Google Scholar
Y. Chen, Y. F. Zhao, J. Yang et al., “Selenium alleviates lipopolysaccharide-induced endometritis via regulating the recruitment of TLR4 into lipid rafts in mice,” Food & Function, vol. 11, no. 1, pp. 200–210, 2020.
View at: Publisher Site | Google Scholar
J. Günther, W. Petzl, I. Bauer et al., “Differentiating Staphylococcus aureus from Escherichia coli mastitis: S. aureus triggers unbalanced immune-dampening and host cell invasion immediately after udder infection,” Scientific Reports, vol. 7, no. 1, p. 4811, 2017.
View at: Publisher Site | Google Scholar
M. A. Islam, M. Takagi, K. Fukuyama et al., “Transcriptome Analysis of the Inflammatory Responses of Bovine Mammary Epithelial Cells: Exploring Immunomodulatory Target Genes for Bovine Mastitis,” Pathogens, vol. 9, p. 200, 2020.
View at: Google Scholar
T. Barrett, S. E. Wilhite, P. Ledoux et al., “NCBI GEO: archive for functional genomics data sets--update,” Nucleic Acids Research, vol. 41, no. Database issue, pp. D991–D995, 2013.
View at: Publisher Site | Google Scholar
R. Edgar, M. Domrachev, and A. E. Lash, “Gene Expression Omnibus: NCBI gene expression and hybridization array data repository,” Nucleic Acids Research, vol. 30, no. 1, pp. 207–210, 2002.
View at: Publisher Site | Google Scholar
M. Tao, R. Li, T. Xu et al., “Flavonoids from the mung bean coat promote longevity and fitness in Caenorhabditis elegans,” Food & Function, vol. 12, no. 17, pp. 8196–8207, 2021.
View at: Publisher Site | Google Scholar
M. C. Zúñiga-López, G. Maturana, G. Campmajó, J. Saurina, and O. Núñez, “Determination of bioactive compounds in sequential extracts of chia leaf (Salvia hispanica L.) using UHPLC-HRMS (Q-Orbitrap) And a Global Evaluation of Antioxidant In Vitro Capacity,” Antioxidants, vol. 10, no. 7, p. 1151, 2021.
View at: Publisher Site | Google Scholar
M. K. Sarkar, A. Kar, A. Jayaraman, S. Kar Mahapatra, and V. Vadivel, “Vadivel, vitexin isolated from Prosopis cineraria leaves induce apoptosis in K-562 leukemia cells via inhibition of the BCR-ABL-Ras-Raf pathway,” The Journal of Pharmacy and Pharmacology, vol. 74, p. 103, 2022.
View at: Google Scholar
P. L. Ruegg, “A 100-year review: mastitis detection, management, and prevention,” Journal of Dairy Science, vol. 100, no. 12, pp. 10381–10397, 2017.
View at: Publisher Site | Google Scholar
A. J. Spitzer, Q. Tian, R. K. Choudhary, and F. Q. Zhao, “Bacterial endotoxin induces oxidative stress and reduces milk protein expression and hypoxia in the mouse mammary gland,” Oxidative Medicine and Cellular Longevity, vol. 2020, Article ID 3894309, 16 pages, 2020.
View at: Google Scholar
S. Schmitz, M. W. Pfaffl, H. H. Meyer, and R. M. Bruckmaier, “Short-term changes of mRNA expression of various inflammatory factors and milk proteins in mammary tissue during LPS-induced mastitis,” Domestic Animal Endocrinology, vol. 26, no. 2, pp. 111–126, 2004.
View at: Publisher Site | Google Scholar
D. S. Malar, M. I. Prasanth, R. B. Shafreen, K. Balamurugan, and K. P. Devi, “Grewia tiliaefolia and its active compound vitexin regulate the expression of glutamate transporters and protect Neuro-2a cells from glutamate toxicity,” Life Sciences, vol. 203, pp. 233–241, 2018.
View at: Publisher Site | Google Scholar
C. L. Xie, J. L. Li, E. X. Xue et al., “Vitexin alleviates ER-stress-activated apoptosis and the related inflammation in chondrocytes and inhibits the degeneration of cartilage in rats,” Food & Function, vol. 9, no. 11, pp. 5740–5749, 2018.
View at: Publisher Site | Google Scholar
Y. H. Kim, T. W. Oh, E. Park et al., “Anti-inflammatory and anti-apoptotic effects of acer Palmatum Thumb. extract, KIOM-2015EW, in a hyperosmolar-stress-induced in vitro dry eye model,” Nutrients, vol. 10, no. 3, p. 282, 2018.
View at: Publisher Site | Google Scholar
Z. Li, T. Liu, Y. Feng et al., “PPARγ alleviates sepsis-induced liver injury by inhibiting hepatocyte pyroptosis via inhibition of the ROS/TXNIP/NLRP3 signaling pathway,” Oxidative Medicine and Cellular Longevity, vol. 2022, Article ID 1269747, 15 pages, 2022.
View at: Google Scholar
S. Nie, Z. Shi, M. Shi et al., “PPARγ/SOD2 protects against mitochondrial ROS-dependent apoptosis via inhibiting ATG4D-mediated mitophagy to promote pancreatic cancer proliferation,” Frontiers in cell and developmental biology, vol. 9, article 745554, 2021.
View at: Google Scholar
S. Ni, D. Li, H. Wei, K. S. Miao, and C. Zhuang, “PPARγ attenuates interleukin-1β-induced cell apoptosis by inhibiting NOX2/ROS/p38MAPK activation in osteoarthritis chondrocytes,” Oxidative Medicine and Cellular Longevity, vol. 2021, Article ID 5551338, 15 pages, 2021.
View at: Google Scholar
F. Urano, X. Wang, A. Bertolotti et al., “Coupling of Stress in the ER to Activation of JNK Protein Kinases by Transmembrane Protein Kinase IRE1,” Science, vol. 287, no. 5453, pp. 664–666, 2000.
View at: Publisher Site | Google Scholar
M. Corazzari, F. Rapino, F. Ciccosanti et al., “Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma,” Cell Death and Differentiation, vol. 22, no. 6, pp. 946–958, 2015.
View at: Publisher Site | Google Scholar
H. Y. Jiang, S. A. Wek, B. C. McGrath et al., “Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses,” Molecular and Cellular Biology, vol. 23, no. 16, pp. 5651–5663, 2003.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2022 Yu Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

664

Downloads

431

Citations